On February 1, Pfizer asked the Food and Drug Administration to authorize emergency use of its Covid vaccine for kids ages six months to four years. Cue parents taking celebratory Chambong hits. Then in a stunning reversal on February 11, the pharmaceutical company announced it would postpone its application until it had data from its latest round of clinical trials. Cue the literal bong hits.
On March 23, more than a month later, the long, frustrating road for parents of toddlers and threenagers took another twist: Moderna announced it plans to submit Covid vaccination data to the FDA for children between six months and six years. (The company will also
→ Continue reading at SeattleMet